Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

VIVUS, Inc.

TRADE

NASDAQ: VVUSHealthcare / Biotechnology / USA
4.46-0.14-3.04%Vol 25 3731Y Perf -44.15%
Oct 17th, 2018 14:04
BID4.46 ASK4.54
Open4.57 Previous Close4.60
Pre-Market- After-Trading-
 - -%  - -%
Target Price
10.00 
Analyst Rating
Hold 3.00
Potencial %
124.22 
Finscreener Ranking
★★★     50.02
Insiders Trans % 3/6/12M
-/80/38 
Value Ranking
★★★     52.72
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
★+     42.80
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)47 
Earnings Rating
Sell
Price Range Ratio 52wk %
17.58 
Earnings Date
6th Nov 2018

Today's Price Range

4.464.68

 

52wk Range

3.309.90

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-13.04%
3 Months
513.33%
6 Months
1 050.00%
1 Year
-44.15%
3 Years
172.19%
5 Years
-52.23%

Quotes

Name / TickerPriceChg.Chg.%
VVUS4.46-0.1400-3.04
AAPL220.87-1.2800-0.58
GOOG1 113.65-7.6300-0.68
MSFT110.44-0.5600-0.50
XOM81.350.15000.18
WFC54.470.74001.38
JNJ139.613.05002.23
FB158.67-0.1100-0.07
GE12.310.21001.74
JPM110.051.43001.32
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.10
Current Ratio 4.90
Long Term Debt to Total Capital 1.00
Total Debt to Equity 661.16
Interest Coverage -0.20
Leverage Ratio -9.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin74.60
EBIT Margin-9.60
EBITDA Margin-6.20
Pre-tax Profit Margin-82.80
Profit Margin-87.33
ValuationValueIndustryS&P 500US Markets
PE Ratio 1.40
PB Ratio 127.20
PS Ratios 0.13
Price to Cash Flow 1.60
Price to Free Cash Flow -0.30
Cash Flow Per Share -2.19
Price to Tangible Book-0.30
Book Value per Share-2.62
Enterprise Value (in ths.)222 308
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-104.86
ROE last 12 Months 352.61
Return on Assets (5Y Avg) -22.35
ROA last 12 Months -13.22
Return on Capital (5Y Avg) -11.25
ROC last 12 Months -2.47
Return on invested Capital Q -2.47
Return on invested Capital Y1.12
Assets Turnover0.10
Receivables Turnover3.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)38 801
Revenue per Share 36.53
Revenue Growth 3 Years -20.06
Revenue Growth 5 Years -1.84
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-1.10-1.20-9.09
Q01 2018-1.10-1.009.09
Q04 2017--1.00-
Q03 2017-1.30-0.6053.85
Q02 2017-1.30-1.300.00
Q01 2017-0.13-0.0192.31
Q04 2016-0.090.54700.00
Q03 2016-0.25-0.0964.00
Earnings Per EndEstimateRevision %Trend
9/2018 QR-1.100.00-
12/2018 QR-1.100.00-
12/2018 FY-4.40-2.33Negative
12/2019 FY-5.700.00-
Next Report Date6th Nov 2018
Estimated EPS Next Report-1.10
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume25 373
Shares Outstanding (in ths.)10 650
Trades Count119
Dollar Volume102 133
Avg. Volume89 501
Avg. Weekly Volume45 612
Avg. Monthly Volume79 143
Avg. Quarterly Volume70 665

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

35%65%

Bearish Bullish

54%46%

Bearish Bullish

73%27%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x